Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

DC Vaccine for Patients With Ductal Carcinoma In Situ (DCIS6)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by University of Pennsylvania
Sponsor:
Information provided by (Responsible Party):
Brian Czerniecki, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT02061332
First received: February 10, 2014
Last updated: February 11, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2019
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)